How does A199730's PB Ratio compare to its peers?

Insufficient data to calculate A199730's Price-To-Book Ratio vs. peers for valuation analysis.

How does A199730's PB Ratio compare vs other companies in the KR Life Sciences Industry?

Insufficient data to calculate A199730's Price-To-Book Ratio vs. industry for valuation analysis.

What is A199730's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate A199730's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of A199730 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate A199730's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

BioInfra (KOSDAQ:A199730) - Stock Price, News & Analysis

A199730 Stock Overview

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

About the company

A199730 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	2/6

Rewards

Risk Analysis

Has not reported any financial data

Highly volatile share price over the past 3 months compared to the KR market

Does not have a meaningful market cap (₩38B)

BioInfra Co., Ltd. Competitors

Green Lifescience

KOSDAQ:A114450

₩39.9b

Aligned Genetics

KOSDAQ:A238120

₩43.7b

WOOJUNG BIO

KOSDAQ:A215380

₩31.9b

Celemics

KOSDAQ:A331920

₩31.1b

Price History & Performance

Summary of all time highs, changes and price drops for BioInfra
Historical stock prices
Current Share Price	₩7,860.00
52 Week High	₩12,930.00
52 Week Low	₩7,000.00
Beta	0
11 Month Change	-22.33%
3 Month Change	-2.96%
1 Year Change	-30.75%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-73.27%

Recent updates

Shareholder Returns

	A199730	KR Life Sciences	KR Market
7D	-0.9%	-1.1%	-0.01%
1Y	-30.7%	42.6%	3.0%

Return vs Industry: A199730 underperformed the KR Life Sciences industry which returned 42.6% over the past year.

Return vs Market: A199730 underperformed the KR Market which returned 3% over the past year.

Price Volatility

Is A199730's price volatile compared to industry and market?
A199730 volatility
A199730 Average Weekly Movement	12.5%
Life Sciences Industry Average Movement	8.8%
Market Average Movement	5.4%
10% most volatile stocks in KR Market	11.5%
10% least volatile stocks in KR Market	2.6%

Stable Share Price: A199730's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A199730's weekly volatility has increased from 7% to 12% over the past year.

About the Company

Founded	Employees	CEO	Website
2007	n/a	n/a	www.bioinfrakorea.co.kr

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea.

BioInfra Co., Ltd. Fundamentals Summary

How do BioInfra's earnings and revenue compare to its market cap?
A199730 fundamental statistics
Market cap	₩37.70b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A199730 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A199730 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A199730 perform over the long term?

See historical performance and comparison

Dividends

7.6%

Current Dividend Yield

n/a

Payout Ratio

BioInfra KOSDAQ:A199730 Stock Report